Korea S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
5,410
KRW
0.00%
+0.19%
-12.60%
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 24, 2022.
September 21, 2022 at 03:06 am EDT
From August 24, 2022 to September 16, 2022, the company has repurchased 158,983 shares, representing 1.42% for KRW 1,024.7 million. With this, the company has completed the repurchase of 158,983 shares, representing 1.42% for KRW 1,024.7 million under the buyback announced on August 24, 2022.
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2025.
Apr. 08
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2024.
Dec. 21
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 18, 2024.
Nov. 16
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2023.
22-12-20
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 18, 2023.
22-11-17
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 24, 2022.
22-09-21
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 24, 2022, has closed with 158,983 shares, representing 1.42% for KRW 1,024.7 million.
22-09-15
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 158,983 shares.
22-08-24
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 19, 2022.
22-08-24
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-08-23
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 19, 2022, has closed with 161,813 shares, representing 1.45% for KRW 1,036.80 million.
22-08-23
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 161,813 shares.
22-08-19
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 12, 2022.
22-08-19
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-08-18
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 12, 2022, has closed with 81,038 shares, representing 0.72% for KRW 512.62 million.
22-08-18
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 81,038 shares.
22-08-11
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-08-11
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback announced on October 10, 2006 has expired.
22-04-08
CI
Jin Yang Pharmaceutical Co., Ltd. announced that it has received KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
21-11-25
CI
Jin Yang Pharmaceutical Co., Ltd. announced that it expects to receive KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
21-11-23
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 17, 2010, has expired.
21-11-17
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2022.
21-04-08
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2021.
20-12-20
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 18, 2021.
20-11-17
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2021.
20-04-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Companyâs products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-12.60% 42.42M +19.62% 43.34B +20.44% 21.96B +10.86% 14.09B +13.07% 13.64B +37.46% 11.43B -8.59% 6.86B -0.05% 6.79B -8.87% 5.73B +8.46% 5.22B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
JIN YANG PHARMACEUTICAL CO., LTD. 
